Equasens Stock

Equasens EBITDA

The EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Equasens (EQS.PA) as of Aug 13, 2026 is 47.73 M EUR. In the previous year, EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) was 59.44 M EUR — a change of -19.71% (lower).

EBITDA

47.73 MEUR

YoY

-19.71%

Last updated:

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Equasens is 2026 47.73 M EUR. EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Equasens was 2025 59.44 M EUR. It decreases by -19.71% lower compared to the previous year.
Access this data via the Eulerpool API

Equasens Stock analysis

What does Equasens do? Pharmagest Interactive SA is a leading provider of digital solutions for pharmacies and healthcare providers. The company was founded in France in 1986 and is headquartered in Villers-lès-Nancy. The company offers a wide range of software solutions for healthcare providers and pharmacies. Its main business areas include pharmacy management systems, healthcare management solutions, and telemedicine solutions. Pharmagest Interactive SA's pharmacy management systems include software solutions for inventory management, prescription management, and billing. The company also provides e-learning courses and training for pharmacies. Its healthcare management solutions focus on patient data management, with features such as patient records, appointment scheduling, and prescription management. These solutions are used by healthcare providers to optimize patient data management and improve patient care. Pharmagest Interactive SA also offers telemedicine solutions, including remote visit applications, online consultations, and teleconsultations. These solutions are particularly useful for patients in rural areas or with limited mobility. The company's products and services include Crossway, a pharmacy management software; LGPI, a patient management software for hospitals and healthcare providers; Noviatek, a digital prescription management system; and Monolog, a cloud-based platform for telemedicine services. In summary, Pharmagest Interactive SA provides a variety of digital solutions for pharmacies and healthcare providers, focusing on optimizing patient data management, inventory management, and billing. The company is also a pioneer in telemedicine solutions. Equasens is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Equasens stock

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Equasens is 47.73 M EUR in 2026.

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Equasens changed from 59.44 M EUR to 47.73 M EUR, representing a -19.71% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) Equasens since 2006 – with annual values, charts, and detailed analysis.

EBITDA measures operating performance before the impact of financial structure, tax environment, and non-cash depreciation charges.

EBITDA = EBIT + Depreciation & Amortization

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s EUR is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s Equasens historically and in real time.

Access this data via the Eulerpool API

Income Statement — Equasens

All Key Metrics — Equasens